SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-019439
Filing Date
2021-08-12
Accepted
2021-08-12 08:29:19
Documents
13
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40505
2 ex99-1.htm EX-99.1 66443
  Complete submission text file 0001493152-21-019439.txt   291073

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crbp-20210812.xsd EX-101.SCH 3036
4 XBRL LABEL FILE crbp-20210812_lab.xml EX-101.LAB 34915
5 XBRL PRESENTATION FILE crbp-20210812_pre.xml EX-101.PRE 22796
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3673
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 211165591
SIC: 2834 Pharmaceutical Preparations